CCS is actively monitoring and responding to the recommendations of the Public Health Agency of Canada regarding coronavirus disease (COVID-19).
Treatments for locally advanced pancreatic cancer
The following are treatment options for locally advanced pancreatic cancer. Your healthcare team will suggest treatments based on your needs and work with you to develop a treatment plan.
Chemotherapy is usually offered for locally advanced pancreatic cancer.
Chemotherapy drugs and drug combinations used to treat locally advanced pancreatic cancer include:
- gemcitabine (Gemzar)
- gemcitabine and nab-paclitaxel (Abraxane)
- FOLFIRINOX – folinic acid (leucovorin), 5-fluorouracil (Adrucil, 5-FU), irinotecan (Camptosar) and oxaliplatin (Eloxatin)
You may be offered radiation therapy for locally advanced pancreatic cancer. Radiation therapy is sometimes given along with chemotherapy (called chemoradiation).
You may be offered surgery to relieve symptoms of locally advanced pancreatic cancer (called palliative surgery).
Stent placement is one of the most common ways to relieve a blockage caused by a pancreatic tumour. A stent is a thin, hollow tube that is placed into the duct to keep it open.
Surgical bypass may be used in some cases. There are different types of surgical bypass used depending on the location of the blockage.
Some clinical trials in Canada are open to people with pancreatic cancer. Clinical trials look at new ways to prevent, find and treat cancer. Find out more about clinical trials.